Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Clinical trial NCT00849667 · TERMINATED
Trial details
- NCT number
- NCT00849667
- Sponsor
- Morphotek
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-16
- Primary completion
- 2012-12-31
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.